College of Cardiology Foundation that "MR examination of non-pacemaker-dependent patients is discouraged and should only be considered in cases where there is a strong clinical indication and in which the benefits clearly outweigh the risks" [1] . With regard to pacemaker-dependent patients, they recommended that MRI examinations "should not be performed unless there are highly compelling circumstances and when the benefits clearly outweigh the risks" [1] . The 2007 American College of Radiology guidelines further reiterate that the presence of implanted cardiac pacemakers should be considered a "relative contraindication" for MRI and should be considered only in a "case-bycase and site-by-site basis" [6] .
College of Cardiology Foundation that "MR examination of non-pacemaker-dependent patients is discouraged and should only be considered in cases where there is a strong clinical indication and in which the benefits clearly outweigh the risks" [1] . With regard to pacemaker-dependent patients, they recommended that MRI examinations "should not be performed unless there are highly compelling circumstances and when the benefits clearly outweigh the risks" [1] . The 2007 American College of Radiology guidelines further reiterate that the presence of implanted cardiac pacemakers should be considered a "relative contraindication" for MRI and should be considered only in a "case-bycase and site-by-site basis" [6] .
However, it has been estimated that a patient with a pacemaker will have a 50-75% probability of being indicated for an MRI study over the lifetime of the device [7] . The aim of this review is to evaluate the literature on patients with pacemakers who underwent MRI examinations to determine its safety and help define a consensus statement.
Materials and Methods
In April 2009, a comprehensive search was conducted involving the electronic peer-reviewed literature databases PubMed and Cochrane Library. These searches were developed in close consultation with an internist, a cardiologist, a radiologist, and a generalist librarian. Reference lists from identified studies and reviews were manually scanned to identify any other relevant studies. A search of ClinicalTrials.gov was also done to identify any studies that were registered as completed but not R ecently, there has been debate about whether patients with cardiac pacemakers can undergo MRI. Risks associated with MRI arise from three distinct mechanisms that could affect the pacemaker: the static magnetic field causing attractive forces, radiofrequency energy causing heat damage, and gradient magnetic fields that could induce electrical currents in the device [1] . Since 2007, there have been at least 17 supposed MRI-associated deaths worldwide among patients with pacemakers, but none of the deaths occurred during appropriate physician-supervised monitoring [2] .
Although there have been numerous published studies showing the ability of patients with pacemakers to undergo MRI without adverse events, past incidents continue to generate interest in this topic. A Cleveland Clinic survey asked academic radiologists and cardiologists whether they would image a patient with a pacemaker. Responses from radiologists suggested that 97% would not do so, whereas 34% of the cardiologists surveyed stated that they would under the right circumstances [3] .
Currently, the U.S. Food and Drug Administration has labeled packages of all cardiac pacemakers as "MRI unsafe," and these examinations are being performed only in specialized centers [4] . The Food and Drug Administration remains concerned that the extent to which arrhythmogenic risk is dependent on scan parameters, MR system, patient and device position, and device design has not been adequately characterized [5] . In
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yet published. Requests for original data were made by contacting authors or principal investigators.
Only articles that had abstracts available in English were included, for a total of 514 titles and abstracts. All studies that involved pacemaker interactions with humans or animals or had in vitro models were included. From the 514 articles identified, those that discussed implantable cardioverter defibrillators and other devices were excluded; duplicate articles were eliminated as well. Case reports or studies with only one test subject and editorials were not included in the analysis from the 107 publications selected, resulting in a total of 31 publications being selected for review (Fig. 1) .
Results

In Vitro Studies
Of the 31 publications identified for the review, 17 were in vitro studies (Table 1) . One study used a magnetic strength of 0.2 T, four studies used a magnetic strength of 0.5 T, nine studies used a magnetic strength of 1.5 T, and three studies used a magnetic strength of 3 T. Specific absorption rate (SAR) levels (the rate at which energy is absorbed by the body when exposed to a radiofrequency energy field) were not determined for 11 studies but ranged from 0.6 W/kg to 3.54 W/kg for the other six studies.
Fourteen MRI studies focused on the pacemaker, one focused on the brain region, one was "extrathoracic," and one study included three MRI scans of the head, two of the lumbar spine, and four of the thorax of a phantom. Twelve pacemaker companies were studied.
Pacemaker function-Pacemaker functioning was evaluated in nine of the studies [8] [9] [10] [11] [12] [13] [14] [15] [16] . Four studies revealed no change in pacemaker function [8, 10, 13, 15] . One study observed inhibition at the most sensitive device settings when the pacemaker was programmed to dual-mode dual-pacing dual-sensing (DDD) mode [14] . Another study observed that there was inhibition in the ventricular pace ventricular sense ventricular inhibited (VVI) mode and complete inhibition of atrial and ventricular lead, as well as rapid ventricular pacing at 150 beats per minute (bpm) in DDD mode [16] . The remaining three studies showed pacemakers switching to demand mode, ventricular backup pacing activation, and electrical reset [4, 9, 11] .
Reed switch activity-Reed switches in a pacemaker are composed of two ferromagnetic strips activated by a magnetic field for the purpose of testing the pacing capacity. One study found that all pacemakers had reed switch operation by static magnetic fields, resulting in asynchronous pacing [16] . However, another study showed that four of 16 pacemakers had reed switch deactivation when the pacemakers were positioned in the bore of the magnet [10] . Another study observed that reed switches were closed in low magnetic fields (< 50 mT) and opened in 50% of the tested orientations in high magnetic fields (> 200 mT) [17] .
Temperature changes-Temperature changes were recorded in six of the studies. One study found a maximum temperature change of 45.9°C at the lead tip with a 1.5-T scan, but the SAR level was not stated [18] . Another study showed a maximum temperature change of 23.5°C at the lead tip at 0.5 T [10] . One study reported that scans of the head and lumbar regions at 1.5 T had temperature changes less than or equal to 0.5°C, whereas chest area temperatures ranged from 0.4°C to 3.6°C at the lead tips [14] . Another study also revealed a temperature change of 11.9°C at 1.5 T when the lead lengths were longer and the pacemaker was placed in the right hemithorax compared with the left hemithorax (6.3°C), whereas one study found temperature changes of less than 4.0°C with the highest temperatures at the tip of the ventricular electrode [8, 19] . One study showed that a brain MRI scan at 3 T with a transmit-receive head coil may have caused a maximum temperature increase at the pacemaker lead tip of 2.98°C [15] .
Battery changes-Two studies showed no changes in battery status at 1.5 T [12, 14] .
Torque-One study determined that, after testing 31 pacemakers, there was no safety risk in modern pacemakers with respect to magnetic force and torque induced by the static magnetic field of a 1.5-T MRI scanner [20] . Torque was significantly reduced in new-generation pacemakers. One study found that the force and torque generated was also negligible [12] . Another study (3 T) showed a mean translation force on the pacemaker of 374.38 ± 392.75 mN and a mean torque of 2.29 ± 4.08 × 10 −3 N × m with normal pacemaker function [15] . One study observed that three pacemakers exhibited angles greater than 45° on both long-bore and short-bore 1.5-T MRI scanning, and four pacemakers exhibited angles greater than 45° on 3-T MRI scanning [21] .
In Vivo Animal Studies
Four publications involved studies using in vivo animal trials (Table 2) . A total of seven dogs and nine pigs were examined at a field strength of 1.5 T [22] [23] [24] . Two dogs were studied at a field strength of 0.15 T [25] . No deaths were reported.
Pacemaker function-One study found that MRI-induced currents were less than or equal to 0.5 mA, which would make them unlikely to cause myocardial capture [22] . Another study showed significant impedance and minor stimulation threshold changes with no pacemaker resets or changes in programmed parameters [23] . However, one study also observed that seven of eight pulse generators paced rapidly when exposed to radiofrequency signal and caused a dramatic decrease in arterial blood pressure [24] .
Reed switch activity-One study found that all pacemakers functioned in an asynchronous mode when placed within a certain distance of the magnet with transient reed switch observation [24] . Another study showed that VVI, atrial synchronous ventricular inhibited, and DDD modes were switched to asynchronous modes as a result of reed switch closure inside the nuclear magnetic resonance field [25] . Zikria et al. ( Table 1 continues on next page) Note-Position 1 of the three-letter placing code defines the chambers paced: A = atrium, V = ventricle, D = dual chamber. Position 2 refers to the chambers sensed: A = atrium, V = ventricle, D = dual chamber, 0 = absence of sensing. Position 3 refers to how the pacemaker responds to sensed events: I = sensed event inhibits the output pulse, D = dual modes of response, 0 = no response to sensed input. DDD = dual-mode dual-spacing dual-sensing, VVI = ventricular pace ventricular sense ventricular inhibited, NS = not specified.
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( Table 1 continues on next page)
Zikria et al.
Temperature changes-One study found temperature increases of up to 20°C, but no heat-induced damage could be seen in histologic analysis, and results of troponin tests were negative at 1.5 T [23] .
In Vivo Human Studies
Fifteen publications involved human subjects (Table 3, Fig. 2 ). A total of 1,419 MRI examinations were performed, with no deaths reported. One study did not state the field strength of the MRI examination, one study was conducted at 0.35 T, four studies were conducted at 0.5 T, eight studies were conducted at 1.5 T, one study was conducted at 2 T, and two studies were conducted at 3 T (Fig. 3) .
One study with 40 examinations did not state the location of the MRI scan conducted. For the remaining 14 studies, MRI scans were performed in the following anatomic locations: brain (n = 677); lumbar spine (n = 504); neck, cervical spine, brachial plexus, and jaw (n = 53); heart (n = 49); abdomen and pelvis (n = 40); lower extremities and knee (n = 35); chest and thorax (n = 11); and upper extremities, including shoulder and arm (n = 10). Of the 677 brain MRI examinations, 464 (68%) were examinations with the Medtronic EnRhythm pacemaker. Of the 504 MRIs of the lumbar spine, 464 (92%) were examinations with the Medtronic EnRhythm pacemaker [26] .
There were 12 studies that involved pacemakers in off or asynchronous modes [10, 15, [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] . Four studies had pacemaker-dependent patients enrolled in their trials and set pacemakers to asynchronous mode [26, 30, 33, 35] . Of the 12 studies that involved brain MRI examinations of patients with pacemakers, three studies used a transmitreceive head coil [15, 26, 30] . Of the 15 trials, six [10, 15, [29] [30] [31] 33] followed patients for 3 months, two studies [26, 35] followed patients for 1 month, and one study [32] followed patients for 1 week.
Pacemaker function-Of the 15 human studies, 11 studies encompassing 1,170 (82%) of 1,419 MRI examinations found no significant change in pacemaker function after MRI examination [10, 26, 27, 29, 30, [32] [33] [34] [35] [36] [37] . Of 1,170 examinations, 928 were conducted at 1.5 T with the use of the Medtronic EnRhythm, the first pacemaker approved in Europe for MRI, at less than or equal to 2.0 W/kg [26] . Without accounting for the Medtronic study, in 242 (49%) of 491 cases, there were no significant changes in pacemaker function after MRI examinations. MRI magnetic strength ranged from 0. Not stated Two pacemakers moved when placed on the MRI bed; all pacemakers showed no effect on the programmed pacemaker settings; in all pacemakers, reed switch was operated by static magnetic field resulting in asynchronous pacing; no pacemakers displayed pacing dysfunction when programmed to VOO or DOO mode; in VVI mode, inhibition was observed on exposing the pacemakers to MRI with the magnet function inactivated; in DDD, complete inhibition of atrial and ventricular lead and isolated sensing/inhibition of one lead was observed, and it also had atrial triggering with consequent rapid ventricular pacing at the [15, 28, 31, 38] . MRI magnet strength ranged from 0.5 to 3 T, with 193 examinations conducted at 1.5 T. SAR levels ranged from 0.08 to less than or equal to 3.2 W/kg. In one cardiac MRI study (at 0.5 T), a patient was removed after the pacemaker programmed to VVI mode during MRI paced at maximum voltage at fixed 100 bpm [28] . One study (at 1.5 T) determined that 37% of leads underwent changes, with 9.4% having significant changes (more than one voltage) and 1.9% of leads requiring change in programmed output [38] . Another study (at 1.5 T) found a significant increase in pacing capture threshold and electrical reset after MRI in seven of 115 examinations, but all were able to be reprogrammed to previous parameters after imaging [31] . A study involving brain MRI (at 3 T) with pacemakers set to asynchronous mode found that eight pacemakers were reset [15] .
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Reed switch activity-Two studies reported changes in reed switch activity during MRI examination [29, 33] . One study found that all patients had reed switch activation in the MRI scanner and deactivation when patients left the scanning room, but 12 (37.5%) of 32 patients had reed switch deactivation when the patients were positioned in the center of the scanner [29] . The reed switch behavior did not depend on pacemaker model or anatomic region investigated. Another study found that 10 devices had reed switch activation by static magnetic field of the MRI that led to transient asynchronous pacing at the device-specific magnet rate of 85 bpm, which ceased on patient positioning in the magnet bore [33] . The Medtronic EnRhythm pacemaker, which accounted for 928 of 1,149 MRI examinations, does not have a reed switch (Cronin C, personal communication).
Symptoms-Of the 15 human studies, two reported symptoms felt by the patient during the MRI [35, 38] . One study observed one patient transiently feeling the pacemaker vibrate during coronary artery imaging [38] . Another study observed one patient reporting 10 seconds of chest burning sensation during a brain scan, but the symptoms resolved before the Note-Position 1 of the three-letter placing code defines the chambers paced: A = atrium, V = ventricle, D = dual chamber. Position 2 refers to the chambers sensed: A = atrium, V = ventricle, D = dual chamber, 0 = absence of sensing. Position 3 refers to how the pacemaker responds to sensed events: I = sensed event inhibits the output pulse, D = dual modes of response, 0 = no response to sensed input. NMR = nuclear magnetic resonance, VVI = ventricular triggered, NS = not specified.
Zikria et al. Position 3 refers to how the pacemaker responds to sensed events: I = sensed event inhibits the output pulse, D = dual modes of response, 0 = no response to sensed input. bpm = beats per minute, NMR = nuclear magnetic resonance, NS = not specified.
( Table 3 continues on next page) Note-Position 1 of the three-letter placing code defines the chambers paced: A = atrium, V = ventricle, D = dual chamber. Position 2 refers to the chambers sensed: A = atrium, V = ventricle, D = dual chamber, 0 = absence of sensing. Position 3 refers to how the pacemaker responds to sensed events: I = sensed event inhibits the output pulse, D = dual modes of response, 0 = no response to sensed input. bpm = beats per minute, NMR = nuclear magnetic resonance, NS = not specified.
(Table 3 continues on next page)
Zikria et al. were uncompromised, and no change in battery status was noted; no device experienced a "Power-on-Reset"; no clinically relevant change in pacing thresholds, sensing, or impedance were noted; one patient reported brief (10 seconds) chest burning during brain scan; no pauses or rapid pacing observed
Note-Position 1 of the three-letter placing code defines the chambers paced: A = atrium, V = ventricle, D = dual chamber. Position 2 refers to the chambers sensed: A = atrium, V = ventricle, D = dual chamber, 0 = absence of sensing. Position 3 refers to how the pacemaker responds to sensed events: I = sensed event inhibits the output pulse, D = dual modes of response, 0 = no response to sensed input. bpm = beats per minute, NMR = nuclear magnetic resonance, NS = not specified.
( Table 3 continues on next page) Note-Position 1 of the three-letter placing code defines the chambers paced: A = atrium, V = ventricle, D = dual chamber. Position 2 refers to the chambers sensed: A = atrium, V = ventricle, D = dual chamber, 0 = absence of sensing.
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Position 3 refers to how the pacemaker responds to sensed events: I = sensed event inhibits the output pulse, D = dual modes of response, 0 = no response to sensed input. bpm = beats per minute, NMR = nuclear magnetic resonance, NS = not specified.
end of the scan [35] . Pacemaker settings were not changed as a result of magnetic interference during these events.
Troponin levels-Of the 15 trials, three studies determined troponin levels for the patients undergoing imaging with the pacemaker [15, 31, 37] . One study (at 1.5 T) reported that there was no statistically significant increase in troponin levels when compared with levels before and after the MRI examination [31] . However, in four of 115 patient examinations, the troponin level increased from a normal baseline value to above-normal values afterward (threshold, 0.1 ng/mL) with one patient also showing an increase in pacing capture threshold [31] . One study of brain MRI scans performed at 3 T reported no significant changes in serum troponin-I level after the MRI scans [15] . One study (at 1.5 T) reported no changes in cardiac troponin-I and myoglobin levels [37] .
Battery changes-Three studies found changes in battery function after MRI examinations, but all of these studies determined that battery function recovered fully at 3 months [15, 29, 31] . Four studies examining battery changes did not find any significant change in battery voltage [26, 32, 33, 35] . One study (at 0.5 T) reported that battery voltage decreased from 2.763 ± 0.043 V before MRI to 2.758 ± 0.044 V immediately after MRI, but 3 months later, battery voltage recovered [29] . One study (at 1.5 T) found a significant (p = 0.0012) decrease in battery voltage immediately after MRI with a maximum decrease of 0.03 V, but there was full recovery at 3-month follow-up, and the decrease did not interfere with pacemaker function [31] . One study (at 3 T) determined that there was also a significant decrease in battery voltage with a transient decrease in 31% (16/51) of cases that returned to baseline values at 3 months of follow-up [15] .
Discussion
There have been case reports of deaths among patients with pacemakers undergoing MRI in both Europe and America [39, 40] . In vitro studies have found oversensing, inhibition of atrial and ventricular output, electric reset, reed switch activity, drastic temperature changes based on the location of the pacemaker and lengths of the leads, and increased torque in older-generation pacemakers. Temperature changes in phantom studies, however, may not indicate true temperature differences in in vivo studies because of the dissipation of heat through circulating blood flow. In vivo animal studies have found that generators paced rapidly when exposed to radiofrequency signal and caused a dramatic decrease in arterial blood pressure. Furthermore, temperature increases of up to 20°C have been observed, despite the fact that no heat-induced damage could be seen in histologic analysis and results of troponin tests were negative in animals [23] . Finally, there are in vivo human trials that have conclud- 
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ed that MRI examinations affect pacemaker function, ECG readings, reed switch activity, symptoms, and battery changes. However, the clinical significance of the trials examined in this review was minor.
Although the American Heart Association considers the presence of a pacemaker a strong relative contraindication to MRI, they state that it can be considered in cases where the potential benefit to the patient clearly outweighs the risks. Furthermore, they recommend obtaining only written informed consent, a person with expertise in MRI physics and safety to optimally plan the scan, the presence of a physician during the scan, and availability of a "crash cart" including a defibrillator during the scan. The pacemaker should be interrogated before and after the procedure. Throughout the scan, visual and voice contact with the patient should be maintained, as well as monitoring of the heart rhythm and vital signs [1] . The 2007 American College of Radiology guidelines reiterate these measures [6] . The area of controversy that arises between the American Heart Association and American College of Radiology guidelines and other reviews involves the decision to reprogram the pacemaker before the MRI examination. Although the American Heart Association and American College of Radiology do not consider it necessary to reprogram the pacemaker, many studies regarding MRI protocol among patients with pacemakers require pacemakers to be placed in an asynchronous mode before imaging.
This review was limited in its conclusions because of the heterogeneous nature of the medical literature. Great variability existed regarding the pacemaker model, patient dependence, anatomic location of the MRI scan, lead polarity, MRI field strength, and SAR to be able to correlate the outcomes. Furthermore, one human study accounts for 928 (65%) of the 1,419 MRI human studies that used the Medtronic EnRhythm pacemaker [26] . SAR also "may not be a valid measure" because "different MR manufacturers incorporate evolving proprietary methodologies to calculate the SAR" and the calculation may vary "considerably even when the same body part, coil, pulse sequence, and the individual patient are held constant on different MR machines-even from the same manufacturer" [30] . For this reason, we have also added the manufacturer of the MRI scanner in our data assessment along with the SAR calculation. Errors in estimations of implant heating with comparison with SAR measurements have also been shown in studies [41, 42] .
A factor that has not been analyzed in our article is the variability of leads. Theoretically, connecting a lead to a different pacemaker could slightly change the maximum heating measured. However, there are many combinations of pacemaker devices and leads available today. Currently, there is testing of MRI with cardiac pacing leads, and one study has determined the safety of fiberoptic leads at 1.5 T and 1.5 W/kg SAR levels [43] .
Another limitation to our review is that we reviewed only English-language articles. When conducting a PubMed search using the query "pacemaker MRI," 262 studies were selected, but this number was reduced to 216 when limited to only English-language articles. Another important consideration is publication bias and "in view of the threats of lawsuits, it clearly would be unusual for all such incidents to be reported in the literature" [3] .
In 82% of MRI examinations, there were no significant changes in pacemaker function after imaging. However, without accounting for the Medtronic study, in 49% of cases, there were no significant changes in pacemaker function after MRI examination. According to our findings, the data on MRI are heterogeneous, and a definitive statement cannot be made about imaging patients with pacemakers. We think that MRI of patients with pacemakers may be considered but with caution and with the benefits outweighing the risks of the examination.
Although various case reports have reported deaths among patients with pacemakers who underwent MRI, no deaths were reported in the studies analyzed in this review. Only one trial was randomized and controlled, with the final results of the study pending publication [26] . Although the data are promising, future studies such as those by Sutton et al. [26] , which are randomized controlled trials, will ultimately change the views of conducting MRI on patients with pacemakers. 
